必要な CMO / CDMO を検索して見つける
貴社の医薬品開発および製造プロジェクトのための高度なスキルを持つパートナーを見つけてください。
BSL (生物学的安全性レベル): 3, 1, 2
規制物質: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
市場: EMA (EU), PMDA (Japan), FDA (USA), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), MFDS (South Korea)
地域: ヨーロッパ
バッチサイズ: Large, Small, Medium
使用: Human
サービス: Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
治療専門分野 (ATC): (C) Cardiovascular system, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (N) Nervous system, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
OEB (職業性暴露バンディング): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
カテゴリ / 製品: サービス, FDF / 医薬品
規制物質: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
コンプライアンス: ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
市場: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), MFDS (South Korea), TGA (Australia)
バッチサイズ: Large, Small, Medium
使用: Human
カテゴリ / 製品: 化学合成品, サービス, FDF / 医薬品, 粒子工学
サービス: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
治療専門分野 (ATC): (C) Cardiovascular system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (S) Sensory organs, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
地域: 北米
OEB (職業性暴露バンディング): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
規制物質: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
市場: EMA (EU), PMDA (Japan), Health Canada (Canada), DIGEMID (Peru), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities, EDE (UAE), TGA (Australia)
地域: ヨーロッパ
コンプライアンス: ISO, UAE Ministry of Health & Prevention, EMA (EU GMP)
使用: Human
サービス: Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
バッチサイズ: Small, Medium
OEB (職業性暴露バンディング): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
カテゴリ / 製品: FDF / 医薬品
Rodon Biologics
Rodon Biologics - RDN Serviços de Biotecnologia
Rodon Biologics は、サードパーティ向けのバイオ医薬品製品の開発において優れたサービスを提供しています。
地域: ヨーロッパ
カテゴリ / 製品: 栄養補助食品, 生物製剤, サービス
BSL (生物学的安全性レベル): 1, 2
サービス: Development services, Analytical / QC services
バッチサイズ: Small
市場: EMA (EU), NMPA (China), FDA (USA), Health Canada (Canada), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE)
地域: ヨーロッパ
コンプライアンス: FDA (cGMP), IFS, Halal Research Council, UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority), EMA (EU GMP), World Health Organization (GMP / HACCP), NSF
カテゴリ / 製品: 栄養補助食品
使用: Human, Veterinary
サービス: Manufacturing services
バッチサイズ: Medium
市場: TGA (Australia), Rest of World, EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India)
バッチサイズ: Small, Medium, Large
OEB (職業性暴露バンディング): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day)
コンプライアンス: NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP)
サービス: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地域: ヨーロッパ
使用: Human, Veterinary
カテゴリ / 製品: 化学合成品
HISTOCELL S.L. | Cell Therapy, Exosomes & Secretomes
HISTOCELL
Histocell はスペインの CDMO で、細胞療法、セクレトーム、エクソソーム、および医療機器を開発、製造しています。
治療専門分野 (ATC): (C) Cardiovascular system, (D) Dermatologicals, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (B) Blood and blood forming organs, (A) Digestive tract and metabolism
市場: MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), CDSCO (India), TGA (Australia), EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities
バッチサイズ: Small, Medium
コンプライアンス: EMA (EU GMP), ISO
カテゴリ / 製品: 生物製剤, サービス, FDF / 医薬品, 化粧品
地域: ヨーロッパ
使用: Human, Veterinary
BSL (生物学的安全性レベル): 1, 2
サービス: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services
OEB (職業性暴露バンディング): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
市場: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World
地域: アジア太平洋
コンプライアンス: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), COFEPRIS, Halal Research Council, ECOVADIS, TGA (Australia GMP), EMA (EU GMP)
バッチサイズ: Large, Small, Medium
カテゴリ / 製品: 化粧品, 栄養補助食品, 化学合成品, サービス
使用: Human, Veterinary
サービス: Development services, Manufacturing services
治療専門分野 (ATC): (C) Cardiovascular system, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (V06) Nutrients
市場: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)
サービス: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地域: ヨーロッパ
コンプライアンス: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)
バッチサイズ: Large, Small, Medium
使用: Human
BSL (生物学的安全性レベル): 1, 2
OEB (職業性暴露バンディング): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
カテゴリ / 製品: 生物製剤
市場: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), EDE (UAE), TGA (Australia)
サービス: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地域: ヨーロッパ
コンプライアンス: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), French Service-Public (CIR), NMPA (China GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
バッチサイズ: Large, Small, Medium
使用: Human
治療専門分野 (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
カテゴリ / 製品: FDF / 医薬品
OEB (職業性暴露バンディング): 1 / low-hazard (PDE > 10,000 µg/day)
市場: EMA (EU)
サービス: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地域: ヨーロッパ
コンプライアンス: ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)
バッチサイズ: Large, Medium
使用: Human
BSL (生物学的安全性レベル): 1, 2
治療専門分野 (ATC): (J) Antiinfectives for systemic use, (R) Respiratory system, (G) Genito urinary system and sex hormones
カテゴリ / 製品: 生物製剤, FDF / 医薬品
市場: EMA (EU), ANVISA (Brazil), CDSCO (India)
サービス: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地域: ヨーロッパ
コンプライアンス: ISO, ANVISA (Brazil B-GMP), EMA (EU GMP), World Health Organization (GMP / HACCP)
使用: Human
BSL (生物学的安全性レベル): 1, 2
治療専門分野 (ATC): (R) Respiratory system, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
バッチサイズ: Small
カテゴリ / 製品: 生物製剤, FDF / 医薬品